Natera · 6 hours ago
Senior/ Research Associate 2
Natera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. They are seeking a Senior Research Associate to support and coordinate workflow activities involved in the execution of molecular and genetic-based assays, ensuring high-quality clinical assays are developed and launched for patient care.
Responsibilities
Independently execute in-lab efforts both manually and using automated liquid handlers to develop non-invasive nucleic acid based diagnostic tests
Experience with automation systems, particularly liquid handling platforms, is required for this role
Assist in the design, execution, and troubleshooting of laboratory workflows in collaboration with scientists, engineers, and cross-functional teams
Perform basic data analysis using tools such as Excel, JMP, or similar software
Contribute to the preparation of reports and other deliverables
Develop and maintain standard operating procedures (SOPs); provide training on established methods as needed
Contribute to the optimization of new methods and technologies supporting next-generation oncology monitoring assays
Coordinate with internal teams (e.g., Laboratory Operations, Scientific Operations, CLIA) to plan and improve logistical workflow processes
Maintain compliance with Natera’s training, security, and privacy standards, including HIPAA/PHI and general policy requirements
Adhere to environmental, health and safety (EHS) guidelines and good laboratory practices (GLP)
Demonstrate flexibility in managing multiple priorities and perform additional duties as assigned
Qualification
Required
BS/BA in a biological science or equivalent
Minimum of 4 years Molecular Biology laboratory experience required
Minimum of 2 - 3 years of industry experience in an assay development department
Experience with automation systems, particularly liquid handling platforms, is required for this role
Hands-on experience with nucleic acid techniques, including DNA manipulation, PCR, qPCR, DNA quantification, and analysis using LabChip and BioAnalyzer systems
Strong background in Next Generation Sequencing (NGS) techniques, protocols, and data analysis workflows
Whole Blood processing (Isolation and extraction experience)
Proficient in target enrichment, circulating cell-free DNA/RNA (cfDNA/cfRNA) processing, and library preparation for sequencing applications
Automation skill set is a must, including experience with developing or executing assays on automated liquid handling platforms
Experience with reagent quality control (QC) and troubleshooting assay performance
Practical knowledge of LIMS/database query tools
Proficient in data analysis using Excel and related software
Strong analytical, organizational, and problem-solving abilities, with exceptional attention to detail
Must have proven interpersonal, communication, computer, and technical skills
Self-motivated, adaptable, and results-driven professional with a demonstrated track record of success in both independent and collaborative projects
Benefits
Comprehensive health benefits (medical, dental, vision)
401(k) with company match
Generous paid time off and company holidays
Additional wellness and work-life benefits
Life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Recent News
2026-01-16
Company data provided by crunchbase